Preclinical study on the efficacy of Panobinostat in hepatocellular carcinomaJan 1, 2017·Chi Tung Choy,Wing Yu Man,Chi Hang Wong,Stephen Lam Chan· 0 min read CiteLast updated on Jan 1, 2017 ← Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI Jan 1, 2018Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg) Jan 1, 2016 →